Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Hepatitis C
94%
Liver Cirrhosis
88%
Hepatitis C Virus
42%
Liver Cancer
36%
Infection
35%
Antiviral Therapy
35%
Cohort Analysis
33%
Interferon
30%
Morbidity
28%
Genetics
26%
Gene Linkage
23%
Hazard Ratio
23%
Chronic Liver Disease
17%
UK Biobank
16%
Chronic Hepatitis C
16%
Decompensated Liver Cirrhosis
16%
Primary Health Care
13%
Liver Disease
12%
Public Health
11%
Prediction Model
10%
Diseases
10%
Mortality Rate
10%
Health Care Cost
8%
Prevalence
8%
Cumulative Incidence
8%
End Stage Liver Disease
8%
Standardized Mortality Ratio
8%
Alcohol-Related Liver Disease
8%
All Cause Mortality
8%
Cancer Diagnosis
7%
Alcohol Consumption
7%
Base
7%
Health Outcomes
7%
Diabetes
7%
Risk Stratification
6%
Antiviral Drug
6%
Prognostic Factor
6%
Finger
6%
Horizontal Disease Transmission
6%
Genome Wide Association Study
6%
Alcoholic Polyneuropathy
6%
Hospital Inpatient
6%
Leg Amputation
6%
Blood Sampling
6%
Public Health Policy
6%
Lipoprotein Lipase
6%
Varices
6%
Pharmacological Treatment
6%
Risk Communication
6%
Keyphrases
Hepatitis C
79%
Hepatocellular Carcinoma
66%
Scotland
34%
Sustained Viral Response
33%
Hepatitis C Virus
32%
Cirrhosis
28%
People Who Inject Drugs
24%
Hepatocellular Carcinoma Surveillance
24%
Liver Cancer
21%
Decompensated Cirrhosis
21%
Direct-acting Antiviral Treatment
20%
Population Impact
19%
Early Detection
17%
Reinfection
13%
Chronic Hepatitis C
13%
Treatment as Prevention
13%
Record Linkage Study
13%
Hepatitis C Virus Treatment
12%
Acute Hepatitis C
12%
Sustained Virological Response
12%
Chronic Liver Disease
11%
Risk Stratification
11%
Liver
11%
Ultrasound
10%
Direct-acting Antivirals
10%
Primary Liver Cancer
9%
Glasgow
9%
Cirrhotic Patients
8%
Chronic Hepatitis C Infection
8%
Viral Clearance
8%
Real-world Cohort
8%
Alcoholic Cirrhosis
8%
Risk Prediction Model
8%
Cost-effectiveness
8%
Hepatology
7%
UK Population
7%
Risk Prediction
7%
Hepatocellular Carcinoma Risk
7%
Alcohol
7%
Natural Experiment
7%
Low Risk
6%
Adjusted Hazard Ratio
6%
Interferon-free Therapy
6%
Population-based Cohort Study
6%
Qresearch
6%
Primary Care Population
6%
Genetic Variation
6%
American Adults
6%
Prognostic Factors
6%
Statistical Aspects
6%